Related Experiment Videos
[Prostatitis]
1Service de médecine interne et des maladies infectieuses, hôpital Robert-Debré, Reims.
Abstract:
Infection of the prostatic gland tissue is frequent, affecting from 4 to 5% of men according to anatomical studies. The classical distinction between acute and chronic prostatitis still too often suggests different diseases, whereas chronic prostatitis in fact is the clinical expression of an initial acute or subacute infection for lack of diagnosis and therefore of an appropriate and sufficiently prolonged treatment. In both acute and chronic prostatitis the pathogens are the same: E. coli at all ages, organisms causing urethritis in young men, Gram-negative and often multiresistant bacilli in iatrogenic infections. Fluoroquinolones, which are active against most of these bacteria and are present in high concentrations in the prostate, are for the moment among the most effective antibacterial agents. But unless they are prescribed at an early stage and for long periods prostatitis may remain a desperately chronic disease.
Insights
Prostatitis, an infection affecting 4-5% of men, is often inadequately treated, leading to chronic conditions. Early diagnosis and prolonged fluoroquinolone treatment are crucial for effectively managing this common prostate infection.
Area of Science:
- Urology
- Infectious Diseases
- Microbiology
Context:
- Prostatic infections affect 4-5% of men.
- Acute and chronic prostatitis are often misclassified as distinct diseases.
- Chronic prostatitis is frequently a consequence of undiagnosed or inadequately treated acute/subacute infections.
Purpose:
- To highlight the common pathogens in prostatitis, including E. coli and multiresistant Gram-negative bacilli.
- To emphasize the role of fluoroquinolones as effective agents due to their prostate penetration.
- To underscore the importance of early and prolonged treatment for successful prostatitis management.
Summary:
- The primary pathogens in prostatitis are consistent across age groups, with E. coli being prevalent.
- Fluoroquinolones demonstrate high efficacy due to their concentration in prostatic tissue.
- Inadequate treatment duration or delayed intervention can result in persistent chronic prostatitis.
Impact:
- Improved diagnostic strategies for prostatitis are needed to differentiate acute from chronic presentations.
- Optimizing antibiotic treatment protocols, particularly the duration and timing of fluoroquinolone use, is essential.
- Recognizing chronic prostatitis as a prolonged manifestation of initial infection can guide more effective therapeutic approaches.